GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹260 Cr | ₹249 Cr | ₹247 Cr | ₹255 Cr | ₹262 Cr |
What is the latest Long Term Provisions ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹260 Cr |
| Mar2025 | ₹249 Cr |
| Mar2024 | ₹247 Cr |
| Mar2023 | ₹255 Cr |
| Mar2022 | ₹262 Cr |
How is Long Term Provisions of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹260 Cr | 4.40 | |
| Mar2025 | ₹249 Cr | 0.66 | |
| Mar2024 | ₹247 Cr | -2.88 | |
| Mar2023 | ₹255 Cr | -2.83 | |
| Mar2022 | ₹262 Cr | - | |
Compare Long Term Provisions of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹52,617.3 Cr | 6% | 19% | 9.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 6% |
19% |
9.6% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses